Opendata, web and dolomites

LiVirIn

3D Liver Organoids: Modelling Host Hepatitis B Virus Interaction

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 LiVirIn project word cloud

Explore the words cloud of the LiVirIn project. It provides you a very rough idea of what is the project "LiVirIn" about.

human    hscs    infection    closed    creation    hampered    infected    an    tropism    thinker    hepatitis    independent    400    carrier    researcher    reactivation    endothelial    efficacy    stellate    prevented    engineering    conferences    annually    drugs    cccdna    appropriate    superior    lack    matrix    narrow    risk    life    biochemical    models    hypothesis    interdisciplinary    virus    particles    publications    cells    antiviral    nucleus    clinically    delivers    boost    industries    hbv    train    encompassing    maturation    circular    disease    industry    international    animal    eradicate    chemotherapy    strategies    liver    sinusoidal    peer    inexhaustible    medical    knowledgeable    stable    covalently    lost    vaccination    million    disseminated    evaluation    organoids    pharmaceutical    inter    hepatocyte    ing    wages    pluripotent    biophysics    3d    vitro    mimics    viral    biophysical    expertise    form    model    hepatocytes    stem    completely    networking    immune    presentations    safe    enormous    source    worldwide    culture    lsecs    causing    hepatic    potent    biology    cure    meetings    dna    academia    mobility    replication    658    pscs    chronically    hypothesize    function    transfer    people    scientific    suppression   

Project "LiVirIn" data sheet

The following table provides information about the project.

Coordinator
KATHOLIEKE UNIVERSITEIT LEUVEN 

Organization address
address: OUDE MARKT 13
city: LEUVEN
postcode: 3000
website: www.kuleuven.be

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Belgium [BE]
 Project website http://www.kuleuven.be/samenwerking/scil/about_us/livirin
 Total cost 172˙800 €
 EC max contribution 172˙800 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2014
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2015
 Duration (year-month-day) from 2015-03-01   to  2017-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    KATHOLIEKE UNIVERSITEIT LEUVEN BE (LEUVEN) coordinator 172˙800.00

Map

 Project objective

An estimated ~400 million people are chronically infected with hepatitis B virus (HBV) infection worldwide, resulting in an estimated $658 million in medical costs and lost wages annually. Although HBV disease can be prevented by vaccination, many people still become infected. Potent and safe drugs are available to eradicate HBV viral particles and clinically ‘cure’ HBV infection. However, during replication HBV delivers a very stable form of viral DNA (covalently closed circular DNA, cccDNA) in the nucleus of the hepatocyte, causing life-long risk of reactivation of HBV infection in case of suppression of the immune system (e.g. chemotherapy). Therefore the pharmaceutical industry is now aiming to develop strategies to eradicate the virus from the infected liver completely. Such studies are hampered by the lack of appropriate in vitro or animal models due to the narrow tropism of HBV for human hepatocytes. The hypothesis of the project is that creation of 3D culture systems encompassing hepatocytes, hepatic stellate cells (HSCs) and liver sinusoidal endothelial cells (LSECs) derived from an inexhaustible source of cells (human pluripotent stem cells (PSCs)) in a matrix that mimics the biophysical and biochemical features of the liver, will be a superior model for the study of HBV infection and evaluation of the efficacy of antiviral drugs. We also hypothesize that such 3D organoids will improve maturation and function of hepatocytes, HSCs and LSECs. The proposed studies are highly interdisciplinary, merging expertise from biology, to biophysics and engineering, with inter-sector mobility, networking, collaboration and knowledge transfer between academia and industries. The knowledge developed will be disseminated by presentations at consortium meetings, international conferences and in peer publications. All these aspects will train the researcher as independent thinker, more knowledgeable in scientific research which will provide an enormous boost to his carrier.

 Publications

year authors and title journal last update
List of publications.
2016 M. Kumar, G. Rustandi, R. Boon, R. S. Patil, P. Roelandt, C. Verfaillie;
2016 TERMIS - Americas Conference and Exhibition San Diego, CA December 11–14, 2016
published pages: S-1-S-156, ISSN: 1937-3341, DOI: 10.1089/ten.tea.2016.5000.abstracts
Tissue Engineering Part A 22/S1 2019-07-24

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LIVIRIN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LIVIRIN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

UQ4ORC (2020)

Uncertainty Quantification And Design Tools For Robust Organic Rankine Cycles

Read More  

ReproMech (2019)

The Molecular Mechanisms of Cell Fate Reprogramming in Vertebrate Eggs

Read More  

MetEpiC (2020)

P53-dependent Metabolic and Epigenetic Reprogramming in Carcinogenesis

Read More